Skip to main content
Jessica McAlpine, MD, Obstetrics & Gynecology, San Francisco, CA

JessicaNellMcAlpineMD

Obstetrics & Gynecology San Francisco, CA

Gynecologic Oncology

Physician

Dr. McAlpine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. McAlpine's full profile

Already have an account?

  • Office

    2775 Laurel St, 6th Floor Academic offices
    Vancouver BC
    San Francisco, CA 94125
    Phone+1 604-875-5608

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 1997 - 2001
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2025
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Publications & Presentations

PubMed

Authored Content

  • Extending the Safety Evidence for Opportunistic Salpingectomy in Prevention of Ovarian Cancer: A Cohort Study from British Columbia, CanadaMay 2018
  • Extending the Safety Evidence for Opportunistic Salpingectomy in Prevention of Ovarian CancerMay 2018

Press Mentions

  • Scientists Discover High-Risk Form of Endometrial Cancer — and How to Test for It — Using AI
    Scientists Discover High-Risk Form of Endometrial Cancer — and How to Test for It — Using AIJune 27th, 2024
  • Endometrial Cancer: A High-Risk Form Discovered
    Endometrial Cancer: A High-Risk Form DiscoveredJuly 3rd, 2024
  • AI Tool Identifies High-Risk Subtype of Endometrial Cancer
    AI Tool Identifies High-Risk Subtype of Endometrial CancerJuly 3rd, 2024